NovaBridge Biosciences launches 2026 omnibus share incentive plan with 11,960,000 shares authorized
NBP•Change-in-control provision
The plan allows accelerated vesting or exercisability on a change in control, subject to the terms of the applicable award.
Annual share capacity and award terms
Annual share capacity increases from 2027 through 2036 to the lesser of 3% of prior year-end shares outstanding or a lower amount set by the board.
Awards under the plan include:
- options
- share appreciation rights
- restricted shares
- share units
- share-based awards
- cash-based awards
The terms of awards are to be set by the compensation committee.
2026 omnibus share incentive plan adopted
NovaBridge Biosciences adopted a 2026 Omnibus Share Incentive Plan effective July 13, 2026, replacing its 2020-2025 equity plans for new grants.
The share pool was set at , equivalent to , with recycling from forfeitures, cash settlements, or tax withholdings.
